Suzhou, China

Yu Bai

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Suzhou Alphamab Co., Ltd., Xin Zhang, Xitian Zhang. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu Bai. Retrieved from https://idiyas.com/inventor/yu-bai-c96phrz0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yu Bai: Innovator in Medical Biology

Introduction

Yu Bai is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of medical biology, particularly in the development of innovative therapeutic solutions. With a focus on single domain antibodies, his work aims to address critical health challenges.

Latest Patents

Yu Bai holds 2 patents related to his groundbreaking research. His latest patents include a single domain antibody and derivative proteins against CTLA4. This invention discloses a CTLA4 binding protein and its applications, especially in treating and preventing diseases relevant to CTLA4, such as tumors. The implications of this research are profound, as it opens new avenues for cancer treatment.

Career Highlights

Throughout his career, Yu Bai has worked with notable companies, including Suzhou Alphamab Co., Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in medical biology.

Collaborations

Yu Bai has collaborated with talented individuals in his field, including Ting Xu and Xiaoxiao Wang. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

In summary, Yu Bai is a distinguished inventor whose work in medical biology, particularly in the development of single domain antibodies, has the potential to transform treatment options for various diseases. His contributions are invaluable to the ongoing advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…